Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
FASEB J ; 27(7): 2600-10, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23515443

RESUMO

Cancer cachexia is characterized by a continuous loss of locomotor skeletal muscle mass, which causes profound muscle weakness. If this atrophy and weakness also occurs in diaphragm muscle, it could lead to respiratory failure, which is a major cause of death in patients with cancer. Thus, the purpose of the current study was to determine whether colon-26 (C-26) cancer cachexia causes diaphragm muscle fiber atrophy and weakness and compromises ventilation. All diaphragm muscle fiber types were significantly atrophied in C-26 mice compared to controls, and the atrophy-related genes, atrogin-1 and MuRF1, significantly increased. Maximum isometric specific force of diaphragm strips, absolute maximal calcium activated force, and maximal specific calcium-activated force of permeabilized diaphragm fibers were all significantly decreased in C-26 mice compared to controls. Further, isotonic contractile properties of the diaphragm were affected to an even greater extent than isometric function. Ventilation measurements demonstrated that C-26 mice have a significantly lower tidal volume compared to controls under basal conditions and, unlike control mice, an inability to increase breathing frequency, tidal volume, and, thus, minute ventilation in response to a respiratory challenge. These data demonstrate that C-26 cancer cachexia causes profound respiratory muscle atrophy and weakness and ventilatory dysfunction.


Assuntos
Caquexia/fisiopatologia , Neoplasias do Colo/fisiopatologia , Diafragma/fisiopatologia , Atrofia Muscular/fisiopatologia , Insuficiência Respiratória/fisiopatologia , Actinas/metabolismo , Animais , Western Blotting , Caquexia/etiologia , Linhagem Celular Tumoral , Neoplasias do Colo/complicações , Diafragma/metabolismo , Diafragma/patologia , Expressão Gênica , Imuno-Histoquímica , Camundongos , Proteínas Musculares/genética , Debilidade Muscular/etiologia , Debilidade Muscular/fisiopatologia , Músculo Esquelético/metabolismo , Músculo Esquelético/patologia , Músculo Esquelético/fisiopatologia , Atrofia Muscular/etiologia , Cadeias Pesadas de Miosina/metabolismo , Insuficiência Respiratória/etiologia , Músculos Respiratórios/metabolismo , Músculos Respiratórios/patologia , Músculos Respiratórios/fisiopatologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Proteínas Ligases SKP Culina F-Box/genética , Proteínas com Motivo Tripartido , Tropomiosina/metabolismo , Troponina/metabolismo , Ubiquitina-Proteína Ligases/genética
2.
PLoS One ; 8(4): e62702, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23614054

RESUMO

Pulmonary hypertension (PH) causes loss of body weight and inspiratory (diaphragm) muscle dysfunction. A model of PH induced by drug (monocrotaline, MCT) has been extensively used in mice to examine the etiology of PH. However, it is unclear if PH induced by MCT in mice reproduces the loss of body weight and diaphragm muscle dysfunction seen in patients. This is a pre-requisite for widespread use of mice to examine mechanisms of cachexia and diaphragm abnormalities in PH. Thus, we measured body and soleus muscle weight, food intake, and diaphragm contractile properties in mice after 6-8 weeks of saline (control) or MCT (600 mg/kg) injections. Body weight progressively decreased in PH mice, while food intake was similar in both groups. PH decreased (P<0.05) diaphragm maximal isometric specific force, maximal shortening velocity, and peak power. Protein carbonyls in whole-diaphragm lysates and the abundance of select myofibrillar proteins were unchanged by PH. Our findings show diaphragm isometric and isotonic contractile abnormalities in a murine model of PH induced by MCT. Overall, the murine model of PH elicited by MCT mimics loss of body weight and diaphragm muscle weakness reported in PH patients.


Assuntos
Hipertensão Pulmonar/patologia , Hipertensão Pulmonar/fisiopatologia , Contração Muscular , Animais , Atrofia/complicações , Peso Corporal/efeitos dos fármacos , Diafragma/efeitos dos fármacos , Diafragma/patologia , Diafragma/fisiopatologia , Modelos Animais de Doenças , Ingestão de Alimentos/efeitos dos fármacos , Hipertensão Pulmonar/complicações , Hipertensão Pulmonar/tratamento farmacológico , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Monocrotalina/farmacologia , Monocrotalina/uso terapêutico , Contração Muscular/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA